Drug Trial Radar · NCT06580678
A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries
Last checked: Nov 19, 2026Latest source record: Jan 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Nov 6, 2024
Primary completion
May 7, 2025
Study completion May 7, 2025
Sponsor
- Lead sponsor
- Byoung-Moo SeoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- HysensBio Co., Ltd
- First posted
- Aug 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate physiologic dentin regeneration and safety of KH001 in the administration of erupted wisdom tooth with dentin caries
Conditions
- Dentin Caries
Interventions
KH001Drug
topical application of KH001
PlaceboDrug
topical application of Water for Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of physiological dentin formationTime frame: Week 5
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul National University Dental Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.